Ddu’s Golden Age in Cross-border Medical Trade

June 22, 2017  Source: Ddu 196

Under the background of the Internet plus era, Ddu is set up by a a talented team, consisting of experienced insiders and Internet elites. Ddu (Drugdu.com) is a global leading pharmaceuticals and medical devices B2B online platform. Different from comprehensive B2B platforms, Ddu is a vertical one focusing on the medical trade industry. It is a bold attempt for traditional industry to accelerate the transformation and upgrading.

With the negative impact of the sluggish demand of external economies, the increasing price competition, the difficulty of industry transformation and so on, pharmaceutical foreign trade grows slowly and faces many difficulties. However, with the gradual implementation of cooperation strategies like the Belt and Road Initiative,  a new dawn has been brought to the upgrading of Chinese traditional health care industry. Lots of cooperation opportunities have generated from countries engaging in the Belt and Road Initiative. Health care industry plays an important role in realizing the Belt and Road Initiative, which allows Ddu to act as a crucial part in the cross-border trade of pharmaceuticals and medical devices.

Meanwhile, basing on users’ demand, Ddu keeps coming up with new ideas. Ddu launched Online-offline service at the end of 2016, a new model for exhibitions. Global suppliers and buyers got in touch with each other easily and efficiently via 3D stereo model, visual display, instant video communication,etc. Within half a year, Ddu has been well know by the industry. There have been over 8,000 registered members while one quarter of them have enjoyed Ddu’s promotion service, including the well-known monitor supplier Shenzhen Hexin zondan Medical Equipment Co. Ltd. (hereinafter referred to as "Zondan"). Zondan tentatively reached a cooperation intention with Stormoff, Russia's largest medical equipment agent.  

Terry Yuan, the founder of Ddu, said that whether from the market or from the policy , the pharmaceutical cross-border B2B had stood in the air. It was reported that relative data of Ddu went well in 2016. The number of registration increase with the growth of 25% in the 4th. It will continue to rise in 2017.

In the future, what Ddu provides is not only information and database, but also the establishment of a medical and trade ecosystem covering all medical and trade users. In order to solve more traditional medical trade difficulties, in 2017, Ddu will optimize the service on the basis of the following five points: Firstly, establish a database of Chinese suppliers, with detailed categories; Secondly, make a trade credit and supervision system for users; Thirdly, realize fast matching of buy offers and agent intents; Fourthly, build an online center for sharing and training; Fifthly, provide the third-party service, including project investigation, business communication, clinical registration, financial guarantee and logistics warehousing.

    .

By editor
Share: